Sales & Earnings In Brief
This article was originally published in The Tan Sheet
Executive Summary
Pfizer’s divested nutrition unit up 9% in Q1; Church & Dwight battles tough environment, toothbrush recall; Cyvex grows but fish meal trends sink Omega Protein; Reliv pins U.S. turnaround hopes on LunaRich launches.
You may also be interested in...
Nestle Pays Nearly $12 Bil. For Desirable Pfizer Nutrition Portfolio
Nestle’s $11.85 billion acquisition of Pfizer’s pediatric nutritionals business came in above or at the upper end of most analysts’ expectations. With the deal, Nestle keeps the portfolio – projected to generate $2.4 billion in 2012 sales – away from rivals Danone and Mead Johnson.
Omega Protein Diversifies In Nutritionals, But Draws Short-Term Doubts
Omega Protein acquired Cyvex Nutrition and InCon Processing in the past 15 months to enter the dietary supplement market and vertically integrate its omega-3 fish oil supply chain. The firm gained from a one-time settlement payment in 2011, but saw underlying earnings fall.
Sales & Earnings In Brief
Bayer credits Aspirin, Aleve for consumer gains; Vitamin Shoppe thinking small with new stores; DSM nutrition grows on volume, Martek performance; more Sales & Earnings In Brief.